{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:07:52Z","timestamp":1792800472473,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Shanghai Clinical Research Center for infectious disease \uff08tuberculosis\uff09","award":["19MC1910800"],"award-info":[{"award-number":["19MC1910800"]}],"id":[{"id":"https:\/\/ror.org\/057tkkm33","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Shanghai key clinical specialty construction project - Tuberculosis department","award":["Shslczdzc03001"],"award-info":[{"award-number":["Shslczdzc03001"]}]},{"name":"Clinical study on the diagnostic value and efficacy of peripheral blood flow cytometry for tuberculosis","award":["fk18008"],"award-info":[{"award-number":["fk18008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Active tuberculosis (ATB) originates from primary\n                      <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                      (MTB) infection or reactivation of latent tuberculosis. Besides bacteriological examination, MTB-reactive immunocytes detection can be an alternative testing for discrimination of active tuberculosis. The purpose of this study is to investigate the accuracy of peripheral blood CD27\n                      <jats:sup>\u2212<\/jats:sup>\n                      CD38\n                      <jats:sup>+<\/jats:sup>\n                      IFN-\u03b3\n                      <jats:sup>+<\/jats:sup>\n                      CD4\n                      <jats:sup>+<\/jats:sup>\n                      T cells in ATB diagnosis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This prospective diagnostic accuracy study was conducted at Shanghai Pulmonary Hospital between January 2019 and December 2021. Patients with ATB, non-tuberculosis mycobacterium infection (NTM), latent tuberculosis infection (LTBI), other respiratory diseases (OD), and healthy individuals (HC) were enrolled. The accuracy of CD27\n                      <jats:sup>\u2212<\/jats:sup>\n                      CD38\n                      <jats:sup>+<\/jats:sup>\n                      IFN-\u03b3\n                      <jats:sup>+<\/jats:sup>\n                      CD4\n                      <jats:sup>+<\/jats:sup>\n                      \/CD4\n                      <jats:sup>+<\/jats:sup>\n                      and other phenotypic markers for ATB diagnosis was assessed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 376 patients (237 ATB, 38 LTBI, 8 NTM, 50 OD, and 43 HC) were enrolled. The ratios of CD4\n                      <jats:sup>+<\/jats:sup>\n                      IFN-\u03b3\n                      <jats:sup>+<\/jats:sup>\n                      CD27\n                      <jats:sup>\u2212<\/jats:sup>\n                      and CD4\n                      <jats:sup>+<\/jats:sup>\n                      IFN-\u03b3\n                      <jats:sup>+<\/jats:sup>\n                      CD27\n                      <jats:sup>\u2212<\/jats:sup>\n                      CD38\n                      <jats:sup>+<\/jats:sup>\n                      profiles in CD4\n                      <jats:sup>+<\/jats:sup>\n                      IFN\n                      <jats:sup>\u2212<\/jats:sup>\n                      \u03b3\n                      <jats:sup>+<\/jats:sup>\n                      cells and the ratios of CD4\n                      <jats:sup>+<\/jats:sup>\n                      IFN-\u03b3\n                      <jats:sup>+<\/jats:sup>\n                      CD38\n                      <jats:sup>+<\/jats:sup>\n                      , CD4\n                      <jats:sup>+<\/jats:sup>\n                      IFN-\u03b3\n                      <jats:sup>+<\/jats:sup>\n                      CD27\n                      <jats:sup>\u2212<\/jats:sup>\n                      , and CD4\n                      <jats:sup>+<\/jats:sup>\n                      IFN-\u03b3\n                      <jats:sup>+<\/jats:sup>\n                      CD38\n                      <jats:sup>+<\/jats:sup>\n                      CD27\n                      <jats:sup>\u2212<\/jats:sup>\n                      profiles in CD4\n                      <jats:sup>+<\/jats:sup>\n                      cells in the ATB group were significantly higher than in the other groups. The area under the curve (AUC) of CD27\n                      <jats:sup>\u2212<\/jats:sup>\n                      CD38\n                      <jats:sup>+<\/jats:sup>\n                      IFN-\u03b3\n                      <jats:sup>+<\/jats:sup>\n                      CD4\n                      <jats:sup>+<\/jats:sup>\n                      \/CD4\n                      <jats:sup>+<\/jats:sup>\n                      for the diagnosis of ATB was the highest, with a value of 0.890. With the optimal cutoff value of 1.34\u2009\u00d7\u200910\n                      <jats:sup>\u20134<\/jats:sup>\n                      , the sensitivity and specificity of CD27\n                      <jats:sup>\u2212<\/jats:sup>\n                      CD38\n                      <jats:sup>+<\/jats:sup>\n                      IFN-\u03b3\n                      <jats:sup>+<\/jats:sup>\n                      CD4\n                      <jats:sup>+<\/jats:sup>\n                      \/CD4\n                      <jats:sup>+<\/jats:sup>\n                      for ATB diagnosis was 0.869 and 0.849, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      CD27\n                      <jats:sup>\u2212<\/jats:sup>\n                      CD38\n                      <jats:sup>+<\/jats:sup>\n                      IFN-\u03b3\n                      <jats:sup>+<\/jats:sup>\n                      CD4\n                      <jats:sup>+<\/jats:sup>\n                      \/CD4\n                      <jats:sup>+<\/jats:sup>\n                      might be a potential biomarker for active tuberculosis diagnosis.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-022-07895-1","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T13:19:54Z","timestamp":1669900794000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Evaluation of Mycobacterium tuberculosis specific antigen-stimulated CD27\u2212CD38+IFN-\u03b3+CD4+ T cells for discrimination of active tuberculosis"],"prefix":"10.1186","volume":"22","author":[{"given":"Yong","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Fei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Sha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,1]]},"reference":[{"issue":"3","key":"7895_CR1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S1473-3099(17)30703-X","volume":"18","author":"GBDT Collaborators","year":"2018","unstructured":"GBDT Collaborators. The global burden of tuberculosis: results from the global burden of disease study 2015. Lancet Infect Dis. 2018;18(3):261\u201384.","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"7895_CR2","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/S1473-3099(18)30654-6","volume":"18","author":"MP Grobusch","year":"2018","unstructured":"Grobusch MP, Kapata N. Global burden of tuberculosis: where we are and what to do. Lancet Infect Dis. 2018;18(12):1291\u20133.","journal-title":"Lancet Infect Dis"},{"key":"7895_CR3","unstructured":"World Health Organization. Global tuberculosis report 2018. World Health Organization. WHO\/CDS\/TB; 2018."},{"issue":"1","key":"7895_CR4","doi-asserted-by":"publisher","first-page":"14601","DOI":"10.1038\/s41598-017-15024-1","volume":"7","author":"S Zhu","year":"2017","unstructured":"Zhu S, et al. The burden and challenges of tuberculosis in China: findings from the global burden of disease study 2015. Sci Rep. 2017;7(1):14601.","journal-title":"Sci Rep"},{"key":"7895_CR5","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1016\/j.ijid.2020.02.034","volume":"92S","author":"X Cui","year":"2020","unstructured":"Cui X, Gao L, Cao B. Management of latent tuberculosis infection in China: exploring solutions suitable for high-burden countries. Int J Infect Dis. 2020;92S:S37\u201340.","journal-title":"Int J Infect Dis"},{"key":"7895_CR6","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00258-2018","author":"JL Galindo","year":"2019","unstructured":"Galindo JL, et al. Comparison of the QuantiFERON-TB and tuberculin skin test for detection of latent tuberculosis infection in cancer patients in a developing country. ERJ Open Res. 2019. https:\/\/doi.org\/10.1183\/23120541.00258-2018.","journal-title":"ERJ Open Res"},{"issue":"8","key":"7895_CR7","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1093\/cid\/civ1223","volume":"62","author":"G Theron","year":"2016","unstructured":"Theron G, et al. Xpert MTB\/RIF results in patients with previous tuberculosis: can we distinguish true from false positive results? Clin Infect Dis. 2016;62(8):995\u20131001.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"7895_CR8","doi-asserted-by":"publisher","first-page":"e01696-17","DOI":"10.1128\/JCM.01696-17","volume":"56","author":"G Theron","year":"2018","unstructured":"Theron G, et al. False-positive Xpert MTB\/RIF results in retested patients with previous tuberculosis: frequency, profile, and prospective clinical outcomes. J Clin Microbiol. 2018;56(3):e01696-17.","journal-title":"J Clin Microbiol"},{"issue":"6","key":"7895_CR9","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S2213-2600(13)70133-4","volume":"1","author":"MP Nicol","year":"2013","unstructured":"Nicol MP. Xpert MTB\/RIF: monitoring response to tuberculosis treatment. Lancet Respir Med. 2013;1(6):427\u20138.","journal-title":"Lancet Respir Med"},{"issue":"2","key":"7895_CR10","first-page":"95","volume":"83","author":"S Kwiatkowska","year":"2015","unstructured":"Kwiatkowska S. The IGRA tests: where are we now? Pneumonol Alergol Pol. 2015;83(2):95\u20137.","journal-title":"Pneumonol Alergol Pol"},{"issue":"25","key":"7895_CR11","doi-asserted-by":"publisher","first-page":"7330","DOI":"10.12998\/wjcc.v9.i25.7330","volume":"9","author":"F Tang","year":"2021","unstructured":"Tang F, et al. Key determinants of misdiagnosis of tracheobronchial tuberculosis among senile patients in contemporary clinical practice: a retrospective analysis. World J Clin Cases. 2021;9(25):7330\u20139.","journal-title":"World J Clin Cases"},{"issue":"7","key":"7895_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/rcr2.797","volume":"9","author":"L Nguyen-Ho","year":"2021","unstructured":"Nguyen-Ho L, Nguyen-Tiet A, Chang YS. Asthma and pulmonary tuberculosis: misdiagnosis or coexistence. Respirol Case Rep. 2021;9(7): e00797.","journal-title":"Respirol Case Rep"},{"issue":"7","key":"7895_CR13","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1148\/rg.2019190109","volume":"39","author":"SY Rodriguez-Takeuchi","year":"2019","unstructured":"Rodriguez-Takeuchi SY, Renjifo ME, Medina FJ. Extrapulmonary tuberculosis: pathophysiology and imaging findings. Radiographics. 2019;39(7):2023\u201337.","journal-title":"Radiographics"},{"issue":"2","key":"7895_CR14","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ijtb.2016.11.028","volume":"64","author":"JJ Cherian","year":"2017","unstructured":"Cherian JJ, et al. Treatment outcome of extrapulmonary tuberculosis under revised national tuberculosis control programme. Indian J Tuberc. 2017;64(2):104\u20138.","journal-title":"Indian J Tuberc"},{"key":"7895_CR15","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3389\/fped.2019.00350","volume":"7","author":"M de Martino","year":"2019","unstructured":"de Martino M, et al. Immune response to Mycobacterium tuberculosis: a narrative review. Front Pediatr. 2019;7:350.","journal-title":"Front Pediatr"},{"issue":"12","key":"7895_CR16","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/cmi.2017.88","volume":"14","author":"CH Liu","year":"2017","unstructured":"Liu CH, Liu H, Ge B. Innate immunity in tuberculosis: host defense vs pathogen evasion. Cell Mol Immunol. 2017;14(12):963\u201375.","journal-title":"Cell Mol Immunol"},{"key":"7895_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.701704","volume":"12","author":"Y Dinur-Schejter","year":"2021","unstructured":"Dinur-Schejter Y, et al. The clinical aspect of adaptor molecules in T cell signaling: lessons learnt from inborn errors of immunity. Front Immunol. 2021;12: 701704.","journal-title":"Front Immunol"},{"issue":"5","key":"7895_CR18","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/s12276-020-0435-8","volume":"52","author":"JR Hwang","year":"2020","unstructured":"Hwang JR, et al. Recent insights of T cell receptor-mediated signaling pathways for T cell activation and development. Exp Mol Med. 2020;52(5):750\u201361.","journal-title":"Exp Mol Med"},{"key":"7895_CR19","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.3389\/fimmu.2018.01481","volume":"9","author":"T Adekambi","year":"2018","unstructured":"Adekambi T, et al. High frequencies of caspase-3 expressing Mycobacterium tuberculosis-specific CD4(+) T cells are associated with active tuberculosis. Front Immunol. 2018;9:1481.","journal-title":"Front Immunol"},{"issue":"5","key":"7895_CR20","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.jinf.2015.07.009","volume":"71","author":"E Petruccioli","year":"2015","unstructured":"Petruccioli E, et al. Assessment of CD27 expression as a tool for active and latent tuberculosis diagnosis. J Infect. 2015;71(5):526\u201333.","journal-title":"J Infect"},{"issue":"8","key":"7895_CR21","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1002\/eji.200939722","volume":"39","author":"F Sallusto","year":"2009","unstructured":"Sallusto F, Lanzavecchia A. Heterogeneity of CD4+ memory T cells: functional modules for tailored immunity. Eur J Immunol. 2009;39(8):2076\u201382.","journal-title":"Eur J Immunol"},{"issue":"1","key":"7895_CR22","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.bbrc.2006.08.066","volume":"349","author":"P Aksoy","year":"2006","unstructured":"Aksoy P, et al. Regulation of SIRT 1 mediated NAD dependent deacetylation: a novel role for the multifunctional enzyme CD38. Biochem Biophys Res Commun. 2006;349(1):353\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"7895_CR23","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.bbrc.2006.05.042","volume":"345","author":"P Aksoy","year":"2006","unstructured":"Aksoy P, et al. Regulation of intracellular levels of NAD: a novel role for CD38. Biochem Biophys Res Commun. 2006;345(4):1386\u201392.","journal-title":"Biochem Biophys Res Commun"},{"key":"7895_CR24","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.3389\/fimmu.2019.01187","volume":"10","author":"KA Hogan","year":"2019","unstructured":"Hogan KA, Chini CCS, Chini EN. The multi-faceted ecto-enzyme CD38: roles in immunomodulation, cancer, aging, and metabolic diseases. Front Immunol. 2019;10:1187.","journal-title":"Front Immunol"},{"key":"7895_CR25","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.3389\/fimmu.2018.03094","volume":"9","author":"I Latorre","year":"2018","unstructured":"Latorre I, et al. Study of CD27 and CCR4 markers on specific CD4(+) T-cells as immune tools for active and latent tuberculosis management. Front Immunol. 2018;9:3094.","journal-title":"Front Immunol"},{"issue":"8","key":"7895_CR26","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1093\/cid\/ciz1070","volume":"71","author":"PS Silveira-Mattos","year":"2020","unstructured":"Silveira-Mattos PS, et al. Differential expression of activation markers by Mycobacterium tuberculosis-specific CD4+ T cell distinguishes extrapulmonary from pulmonary tuberculosis and latent infection. Clin Infect Dis. 2020;71(8):1905\u201311.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"7895_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12865-021-00430-y","volume":"22","author":"F Xu","year":"2021","unstructured":"Xu F, et al. Assessment of CD27 expression on T-cells as a diagnostic and therapeutic tool for patients with smear-negative pulmonary tuberculosis. BMC Immunol. 2021;22(1):41.","journal-title":"BMC Immunol"},{"issue":"15","key":"7895_CR28","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1024\/1661-8157\/a003370","volume":"108","author":"A Arpagaus","year":"2019","unstructured":"Arpagaus A, Weisser M. CME: extrapulmonary tuberculosis. Praxis. 2019;108(15):1019\u201326.","journal-title":"Praxis"},{"issue":"Suppl 5","key":"7895_CR29","first-page":"S72","volume":"14","author":"S Stelianides","year":"1997","unstructured":"Stelianides S, Belmatoug N, Fantin B. Manifestations and diagnosis of extrapulmonary tuberculosis. Rev Mal Respir. 1997;14(Suppl 5):S72-87.","journal-title":"Rev Mal Respir"},{"issue":"16","key":"7895_CR30","first-page":"20455","volume":"18","author":"Eurosurveillance Editorial Team","year":"2013","unstructured":"Eurosurveillance Editorial Team. WHO revised definitions and reporting framework for tuberculosis. Euro Surveill. 2013;18(16):20455.","journal-title":"Euro Surveill"},{"key":"7895_CR31","unstructured":"WHO. Latent tuberculosis infection updated and consolidated guidelines for programmatic management. Geneva: World Health Organization; 2018. Licence: CC BY-NC-SA 3.0 IGO. 2018."},{"key":"7895_CR32","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.3389\/fimmu.2018.02247","volume":"9","author":"MIM Ahmed","year":"2018","unstructured":"Ahmed MIM, et al. Phenotypic changes on Mycobacterium tuberculosis-specific CD4 T cells as surrogate markers for tuberculosis treatment efficacy. Front Immunol. 2018;9:2247.","journal-title":"Front Immunol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07895-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07895-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07895-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T13:20:28Z","timestamp":1669900828000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07895-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["7895"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07895-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,1]]},"assertion":[{"value":"29 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study complied with the Declaration of Helsinki and was approved by the Ethics Committee of Shanghai Pulmonary Hospital. And informed consent was obtained from All participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"899"}}